Shots of Alzheimer’s Drug Leqembi as Effective as IV

Published on October 26, 2023

Researchers have shown that the injected version of Eisai and Biogen’s Alzheimer’s drug Leqembi is just as effective as the intravenous form in eliminating toxic brain plaques. This finding is like discovering that a sports car performs just as well on a winding mountain road as it does on a straight highway. The weekly shot form of Leqembi, given as two consecutive injections, has been demonstrated to be equally powerful in removing the damaging plaques that contribute to Alzheimer’s disease. This study suggests that the ease and convenience of a simple injection can bring about the same positive results as more invasive delivery methods. The analysis presented by Eisai provides evidence for healthcare professionals and patients alike that the switch from intravenous to subcutaneous administration does not sacrifice effectiveness. To learn more about this groundbreaking research and its potential impact on the treatment of Alzheimer’s disease, delve into the underlying study.

An injected version of Eisai and Biogen’s Alzheimer’s drug Leqembi works as well as the current intravenous version at removing toxic brain plaques, according to an analysis presented by Eisai on Wednesday. A weekly shot form of Leqembi, given as two consecutive injections,…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>